Mylan defends chairman to ISS ahead of June 22 investor vote

June 7, 2017 (Reuters) – Mylan NV defended Chairman Robert Coury’s role to ISS this week as the influential proxy firm prepares to advise shareholders on how they should vote on the re-election of Coury and other directors, according to a letter the drugmaker released on Wednesday. New York City and State pension funds and the California Teachers’ Retirement System are urging shareholders to vote on June 22 against Coury and five other directors because of the board’s oversight of Coury’s high pay package and issues related to its EpiPen…

Read More